Drug intelligence / Profile preview

Schisandra chinensis extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Schisandra chinensis extract is derived from the fruit of the Schisandra chinensis plant, a deciduous woody vine native to Northern China, Korea, and the Russian Far East. It has a long history of use in traditional Chinese medicine as an adaptogen and tonic for improving resistance to stress and disease. The extract contains lignans such as schizandrin and gamma-schizandrin that are believed to contribute to its pharmacological effects. Mechanistically, it exhibits adaptogenic properties by modulating stress response pathways and demonstrates hepatoprotective effects through antioxidant activity and inhibition of liver enzymes involved in drug metabolism (notably CYP3A4/5). Clinical studies suggest potential benefits for mental performance (improving concentration), liver protection (reducing markers of liver damage), physical endurance, menopausal symptoms relief, metabolic health improvement (including diabetes management), blood pressure regulation, and possible reduction in side effects from immunosuppressant drugs like tacrolimus. However, robust clinical evidence is limited[1][2][3][4][5][8].

Brand names
wu wei zi
Other names
schisandraschizandraSchisandrae Fructuswu wei zi
02

Targets

CYP2C19 (Cytochrome P450 2C19)ABCB1 (P-glycoprotein)CYP1A2 (Cytochrome P450 1A2)CYP3A4 (Cytochrome P450 3A4)CYP2B6 (Cytochrome P450 2B6)

Beyond the preview

Go deeper on Schisandra chinensis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schisandra chinensis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call